No association between opioids, breast cancer recurrence
the ONA take:
There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence, a new study published online ahead of print in the journal Cancer has shown.
Because opioids may affect immune function, researchers sought to determine whether postdiagnosis opioid use is associated with breast cancer recurrence. For the retrospective analysis, researchers identified 34,188 patients with incident, early stage breast cancer who were diagnosed between 1996 and 2008 in Denmark.
Results showed that there was no association between ever-use of opioids and breast cancer recurrence. When researchers adjusted for opioid type, strength, duration of use, and cumulative dose, there was still no association.
Researchers found that breast cancer recurrence rates were lower among users of strongly immunosuppressive opioids, but they note that bias could have been a contributing factor.
The findings suggest that opioids, which are frequently use to manage painassociated with comorbid conditions during cancer survivorship, do not increase the risk for developing breast cancer recurrence.
There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|